All treatments
Treatment
Placebo preparation for subcutanoues use with appearance clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase II and Phase III (Integrated)
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from Olea europaea pollen allergy
This study is testing a new treatment for olive pollen allergy. It's looking at how well different doses of an injection, called CLU-RX-OLE, can reduce allergy symptoms like sneezing and runny nose, and if it's safe to use.
For: Moderate-to-severe allergic rhinitis / rhinoconjunctivitis due to olive pollen for at least two years according to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelineSpain - Ongoing, recruitingPhase II and Phase III (Integrated)
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from house dust mite allergy
This study is testing a new injection treatment for house dust mite allergy. It aims to see if different doses of the treatment can reduce hay fever-like symptoms like sneezing and runny nose, and if it's safe to use, compared to a dummy injection.
For: Moderate-to-severe allergic rhinitis / rhino-conjunctivitis due to house dust mites (HDM) for at least one year according to the "Allergic Rhinitis and its Impact on Asthma" (ARIA · Bousquet et al.Spain · Germany